Type I Interferonopathies
Rheumatic Disease Clinics of North America · 2023-11 · 49 (4) · 741-756
DOI: 10.1016/j.rdc.2023.06.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Rheumatic Disease Clinics of North America, 2023-11. Verfasst von Christine S Wang. Beteiligte Einrichtung: Department of Pediatric Rheumatology, C.S. Mott Children's Hospital, University of Michigan, 1500 East Medical Center Drive SPC 5718, Ann Arbor, MI 4…. Hauptthemen laut MEDLINE: Autoimmune Diseases of the Nervous System, Interferon Type I, Nervous System Malformations. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 91 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Rheumatology, C.S. Mott Children's Hospital, University of Michigan, 1500 East Medical Center Drive SPC 5718, Ann Arbor, MI 48109, USA. Electronic address: chrswang@med.umich.edu.
Zitieren
APA
Wang, C. S. (2023). Type I Interferonopathies. Rheumatic Disease Clinics of North America, 49(4), 741-756. https://doi.org/10.1016/j.rdc.2023.06.002
Vancouver
Wang CS. Type I Interferonopathies. Rheumatic Disease Clinics of North America. 2023;49(4):741-756. doi:10.1016/j.rdc.2023.06.002
BibTeX
@article{Wang2023,
author = {Wang, Christine S},
title = {Type I Interferonopathies},
journal = {Rheumatic Disease Clinics of North America},
year = {2023},
volume = {49},
number = {4},
pages = {741--756},
doi = {10.1016/j.rdc.2023.06.002}
}
EUVIMED